Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    22691169 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)
Condition: Psoriasis
Intervention: Drug: Sitagliptin (Januvia)
2 Recruiting Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
3 Recruiting The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
Condition: Diabetic Kidney Disease
Intervention: Drug: Liraglutide

Indicates status has not been verified in more than two years